IMVT

IMMUNOVANT INC

IMVT·45258J102·US·Common Stock·Healthcare - Biotechnology-Activist

IMVT (IMMUNOVANT INC) is held by 127 institutional investors as of Q1 2026. Largest holders: FMR LLC ($421M), BlackRock, Inc. ($163.3M), BAKER BROS. ADVISORS LP ($135.6M). Net institutional sentiment: Bullish. In Q1 2026, 1 member of Congress and 88 funds bought IMVT.

127
Holders
Avg rating(17 Elite)
$1.8B
Total Value
74% (133)
Fund Consensus
88 buying - 31 selling
IMVTSmart Money Verdict
View all
Held by 127 funds
17 elite
Who's Trading
InsiderGMGloria MelanieSell $76KJul 8, 2026
InsiderGMGloria MelanieSell $4KJul 8, 2026
InsiderSSStout Jay SSell $75KJul 8, 2026
InsiderSSStout Jay SSell $4KJul 8, 2026
InsiderSSStout Jay SSell $55KJul 8, 2026
InsiderSSStout Jay SSell $3KJul 8, 2026
ActivistRSRoivant Sciences Ltd.55.9%Dec 12, 2025
ActivistFMR LLCFMR LLC8.4%Nov 5, 2025
CongressDonald J. TrumpDonald J. TrumpSale $15,001 - $50,000Apr 4, 2025
CongressDonald J. TrumpDonald J. TrumpBuy $15,001 - $50,000Mar 5, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
16.9M(-0.3%)$421M0.0%+76.34%
0
Increased
6.6M(+8.5%)$163.3M0.0%+69.48%
33
Unchanged
5.5M$135.6M0.8%+81.99%
0
Increased
4.5M(+19.8%)$112.7M0.0%+21.41%
36
Decreased
3.9M(-20.0%)$96.3M0.0%+69.21%
0
New
3.7M$92M0.0%+48.67%
41
New
3.6M$89.9M0.0%+48.67%
41
Increased
3.2M(+356.4%)$79.4M0.1%+50.35%
48
Decreased
3.2M$78.9M0.8%+56.65%
0
Increased
2.1M(+12.6%)$52M0.0%+50.04%
33
Unchanged
2M$49.1M0.2%+73.89%
0
Increased
1.8M(+37.7%)$44.3M0.0%+80.89%
38
Increased
1.5M(+128x)$38.4M0.2%+48.68%
56
Decreased
1.2M(-2.0%)$28.8M0.0%+56.70%
0
Increased
893,678(+185.1%)$22.2M0.0%+57.68%
46
Decreased
684,551(-6.5%)$17M0.0%+70.67%
0
Unchanged
680,372$16.9M0.1%+56.65%
0
Increased
672,774(+18.8%)$16.7M0.0%+50.43%
33
Increased
660,438(+2.7%)$16.4M0.0%+52.25%
29
Increased
617,807(+138.4%)$15.3M0.0%+61.01%
45

Showing 1-20 of 133

1 / 7

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used